Holen Sie sich die Stockscreener-App
0.707
5.73%
-0.043
Handel nachbörslich:
.71
0.003
+0.42%
Schlusskurs vom Vortag:
$0.75
Offen:
$0.757
24-Stunden-Volumen:
616.85K
Relative Volume:
0.61
Marktkapitalisierung:
$112.21M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-41.23M
KGV:
-1.01
EPS:
-0.7
Netto-Cashflow:
$-11.54M
1W Leistung:
-10.78%
1M Leistung:
-57.41%
6M Leistung:
-50.90%
1J Leistung:
-84.56%
1-Tages-Spanne:
$0.70
$0.7767
1-Wochen-Bereich:
$0.70
$0.935
52-Wochen-Spanne:
$0.395
$5.25
Renovaro Inc Stock (RENB) Company Profile
Firmenname
Renovaro Inc
Sektor
Branche
Telefon
45 39179840
Adresse
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Vergleichen Sie RENB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RENB
Renovaro Inc
|
0.707 | 112.21M | 0 | -41.23M | -11.54M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Renovaro Inc Aktie (RENB) Neueste Nachrichten
Short Interest in Renovaro Inc. (NASDAQ:RENB) Rises By 30.7% - MarketBeat
Renovaro Inc. appoints new CFO Nathen Fuentes By Investing.com - Investing.com South Africa
Renovaro Inc. appoints new CFO Nathen Fuentes - Investing.com
Geode Capital Management LLC Decreases Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World
Barclays PLC Has $34,000 Stock Position in Renovaro Inc. (NASDAQ:RENB) - Defense World
Renovaro To Buy Predictive Oncology in All-Stock Deal - Pulse 2.0
Renovaro Biosciences Subsidiary Appoints New CEO - MSN
Renovaro appoints Nathen Fuentes as finance chief - MSN
Renovaro Biosciences Merges with Predictive Oncology - MSN
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Predictive Oncology Inc.POAI - The Malaysian Reserve
PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc.POAI - Marketscreener.com
Renovaro Inc. appoints new CEO for subsidiary By Investing.com - Investing.com Australia
Nathen Fuentes Joins Renovaro as Chief Financial Officer - citybiz
Renovaro BioSciences issues shareholder letter, provides corporate update - TipRanks
Renovaro Taps Nathen Fuentes as Finance Chief - MarketWatch
Renovaro Issues Shareholder Letter and Provides Corporate Update - The Manila Times
Renovaro Inc. appoints new CEO for subsidiary - Investing.com
Renovaro To Buy Predictive Oncology In All-Stock Deal - Pulse 2.0
Predictive Oncology shares rise 71% as takeover by Renovaro is announced - Mugglehead
Renovaro to Acquire Predictive Oncology - citybiz
M&A: Predictive Oncology to be Acquired by Renovaro - HIT Consultant
POAI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Predictive Oncology Inc. Is Fair to Shareholders - Business Wire
Renovaro to acquire Predictive Oncology in all-stock transaction - TipRanks
Renovaro to Acquire Predictive Oncology in All-Stock Transaction - The Manila Times
Predictive Oncology in Deal to Be Sold to Renovaro - MarketWatch
Renovaro to Acquire Predictive Oncology in All-Stock Transaction - Benzinga
Predictive Oncology Announces Agreement to be Acquired by Renovaro - GlobeNewswire
Predictive Oncology to Be Acquired by Renovaro in AI-Driven Cancer Research Merger - StockTitan
Renovaro Inc. entered into a binding letter of intent to acquire Predictive Oncology Inc. for for $6.2 million. - Marketscreener.com
State Street Corp Acquires 48,114 Shares of Renovaro Inc. (NASDAQ:RENB) - Defense World
Short Interest in Renovaro Inc. (NASDAQ:RENB) Expands By 27.7% - MarketBeat
Renovaro appoints new CEO for AI-driven diagnostics arm By Investing.com - Investing.com South Africa
Renovaro Inc. Appoints Maurice van Tilburg as CEO of RenovaroCube Amid Strategic Growth in AI-Powered Cancer Diagnostics - Tandav Media
Renovaro appoints new CEO for AI-driven diagnostics arm - Investing.com India
Renovaro Inc. Appoints Maurice van Tilburg as CEO of RenovaroCube to Advance AI-Powered Cancer Diagnostics - Tandav Media
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV - The Manila Times
RENB Stock Price and Chart — NASDAQ:RENB - TradingView
Renovaro Inc. Receives Grant Approval for LUMINA Project, an AI-Powered Minimal Residual Disease Detection Platform for Lung Cancer - Nasdaq
RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program - GlobeNewswire
Renovaro regains Nasdaq compliance with bid price rule - Investing.com India
Renovaro Regains Compliance with NASDAQ Listing Requirement - The Manila Times
Strategic Collaboration with Nebul to Employ NVIDIA Cutting - openPR
Renovaro teams up with Nebul for AI-driven cancer detection - Investing.com
Renovaro Inc. Partners with Nebul to Launch GEDi CUBE Next Generation AI Healthcare Cloud Solutions - Nasdaq
Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection - GlobeNewswire
Renovaro (NASDAQ:RENB) Stock Price Up 2.3%Here's What Happened - MarketBeat
Renovaro (NASDAQ:RENB) Trading Up 6.5%What's Next? - MarketBeat
Renovaro: Fiscal Q1 Earnings Snapshot - New Haven Register
Finanzdaten der Renovaro Inc-Aktie (RENB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
4.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):